Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annual Review of Pathology

• Publication date

  2018-01-24

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology

• Identifiers
  DOI 10.1146/annurev-pathol-020117-043644PMID 29099651PMCID PMC5911915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol and Brain Mitochondria: a Review

  2018cited by this paper
• Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options

  2017cited by this paper
• Fly Models of Human Diseases: Drosophila as a Model for Understanding Human Mitochondrial Mutations and Disease.

  2017cited by this paper
• Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1

  2017cited by this paper
• Generation and Characterization of Induced Pluripotent Stem Cells from Patients with mtDNA Mutations.

  2016cited by this paper
• Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disorders.

  2016cited by this paper
• A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease

  2016cited by this paper
• Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism.

  2016cited by this paper
• The disulfide compound α-lipoic acid and its derivatives: A novel class of anticancer agents targeting mitochondria.

  2016cited by this paper
• Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

  2016influential reference
• Mitochondrial disease patients' perception of dietary supplements' use.

  2016cited by this paper
• C. elegans as a model organism for human mitochondrial associated disorders.

  2016cited by this paper
• Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages

  2016cited by this paper
• A Drosophila model for mito-nuclear diseases generated by an incompatible interaction between tRNA and tRNA synthetase

  2015cited by this paper
• Genetic mosaic analysis of a deleterious mitochondrial DNA mutation in Drosophila reveals novel aspects of mitochondrial regulation and function

  2015cited by this paper
• Disorders of carnitine biosynthesis and transport.

  2015cited by this paper
• Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I–Mutant Fibroblasts

  2015cited by this paper
• Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.

  2015cited by this paper
• Metabolic rescue in pluripotent cells from patients with mtDNA disease

  2015cited by this paper
• mtDNA Mutagenesis Disrupts Pluripotent Stem Cell Function by Altering Redox Signaling

  2015cited by this paper
• α-Lipoic acid as a triglyceride-lowering nutraceutical.

  2015cited by this paper
• Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome

  2015cited by this paper
• Auditory Pathology in a Transgenic mtTFB1 Mouse Model of Mitochondrial Deafness.

  2015cited by this paper
• Cyclophilin D, a target for counteracting skeletal muscle dysfunction in mitochondrial myopathy.

  2015cited by this paper
• Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial Diseases.

  2015cited by this paper
• G7731A mutation in mouse mitochondrial tRNALys regulates late-onset disorders in transmitochondrial mice.

  2015cited by this paper
• Emerging concepts in the therapy of mitochondrial disease.

  2015cited by this paper
• Mitochondrial myopathy biomarker Fibroblast growth factor 21 is induced by muscle mtDNA instability and translation defects

  2015cited by this paper
• Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies

  2015cited by this paper
• Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

  2015cited by this paper
• Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research.

  2015cited by this paper
• Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

  2015cited by this paper
• Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.

  2015cited by this paper
• L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome

  2015cited by this paper
• Polymerase Gamma Mutator (PolG) Mice Rely on Increased Glycolytic Flux for Energy Production

  2015cited by this paper
• Pharmacologic targeting of sirtuin and PPAR signaling improves longevity and mitochondrial physiology in respiratory chain complex I mutant Caenorhabditis elegans.

  2015cited by this paper
• Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease

  2015cited by this paper
• Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNATrp

  2015cited by this paper
• Mitochondrial disease patients' perception of dietary supplements' use

  2015cited by this paper
• Creatine biosynthesis and transport in health and disease.

  2015cited by this paper
• Clinical and radiologic reversal of stroke-like episodes in MELAS with high-dose l-arginine

  2015cited by this paper
• Cardiac Metabolic Pathways Affected in the Mouse Model of Barth Syndrome

  2015cited by this paper
• Determination of lipoic acid in biological samples.

  2015cited by this paper
• Pathomechanisms in Coenzyme Q10-Deficient Human Fibroblasts

  2014cited by this paper
• Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

  2014cited by this paper
• Zebrafish models for translational neuroscience research: from tank to bedside.

  2014cited by this paper
• The Molecular and Metabolic Influence of Long Term Agmatine Consumption*

  2014influential reference
• Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling.

  2014cited by this paper
• rganelles in focus itochondria : Mitochondrial OXPHOS ( dys ) function ex vivo – The se of primary fibroblasts

  2014cited by this paper
• Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3

  2014cited by this paper
• Coenzyme Q10 as a therapy for mitochondrial disease.

  2014cited by this paper
• Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases

  2014cited by this paper
• Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response

  2014cited by this paper
• Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo.

  2014cited by this paper
• Zebrafish as a model system for mitochondrial biology and diseases.

  2014cited by this paper
• Treatment of Mitochondrial Disorders

  2014cited by this paper
• Administration of an Antioxidant Prevents Lymphoma Development in Transmitochondrial Mice Overproducing Reactive Oxygen Species

  2014cited by this paper
• Leigh Syndrome in Drosophila melanogaster

  2014cited by this paper
• Defects of thiamine transport and metabolism

  2014cited by this paper
• Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

  2014cited by this paper
• L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.

  2014cited by this paper
• Transmitochondrial mice as models for primary prevention of diseases caused by mutation in the tRNALys gene

  2014cited by this paper
• Tissue‐specific oxidative stress and loss of mitochondria in CoQ‐deficient Pdss2 mutant mice

  2013cited by this paper
• Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential.

  2013cited by this paper
• Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases

  2013cited by this paper
• Efficient In Vivo Genome Editing Using RNA-Guided Nucleases

  2013cited by this paper
• Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

  2013cited by this paper
• Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome[S]

  2013cited by this paper
• Pilot study: Modified Atkins diet trial for adult-onset mitochondrial myopathy

  2013cited by this paper
• Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.

  2013cited by this paper
• An Incompatibility between a Mitochondrial tRNA and Its Nuclear-Encoded tRNA Synthetase Compromises Development and Fitness in Drosophila

  2013cited by this paper
• Primary Respiratory Chain Disease Causes Tissue-Specific Dysregulation of the Global Transcriptome and Nutrient-Sensing Signaling Network

  2013cited by this paper
• Biotin-responsive basal ganglia disease revisited

  2013cited by this paper
• Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease

  2013cited by this paper
• mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome

  2013cited by this paper
• Mitochondrial encephalomyopathy due to a novel mutation in ACAD9.

  2013cited by this paper
• Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice

  2013cited by this paper
• Disease‐Causing Mitochondrial Heteroplasmy Segregated Within Induced Pluripotent Stem Cell Clones Derived from a Patient with MELAS

  2013cited by this paper
• O21 – 1552 Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings

  2013cited by this paper
• The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome

  2013cited by this paper
• Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ10)

  2012cited by this paper
• Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts.

  2012cited by this paper
• Tafazzin Knockdown in Mice Leads to a Developmental Cardiomyopathy With Early Diastolic Dysfunction Preceding Myocardial Noncompaction

  2012cited by this paper
• Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich’s ataxia

  2012cited by this paper
• Treatment for mitochondrial disorders.

  2012cited by this paper
• Mutations in the Mitochondrial Methionyl-tRNA Synthetase Cause a Neurodegenerative Phenotype in Flies and a Recessive Ataxia (ARSAL) in Humans

  2012cited by this paper
• Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

  2012cited by this paper
• Cardiac electrophysiology in mice: a matter of size

  2012cited by this paper
• Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.

  2012cited by this paper
• Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

  2012cited by this paper
• Genetic causes of cerebral folate deficiency: clinical, biochemical and therapeutic aspects.

  2012cited by this paper
• Ketogenic diets: new advances for metabolism-based therapies.

  2012cited by this paper
• Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha

  2012cited by this paper
• Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease

  2012cited by this paper
• Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness.

  2012cited by this paper
• Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.

  2011cited by this paper
• FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.

  2011cited by this paper
• Characterization of a Transgenic Short Hairpin RNA-Induced Murine Model of Tafazzin Deficiency

  2011cited by this paper
• Targeted gene disruption in somatic zebrafish cells using engineered TALENs

  2011cited by this paper
• The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway

  2011cited by this paper

• Mitochondrial Dysfunction in Propionic Acidemia: A Case‐Report and Review of the Literature

  2026cites this paper
• NDUFV1 mutation presenting as isolated progressive optic neuropathy: a unique manifestation of mitochondrial complex I deficiency

  2025cites this paper
• Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases

  2025cites this paper
• Impact of dietary intervention and supplementation on the physiological profile of individuals with down syndrome

  2025cites this paper
• Targeting trophoblast cell mitochondrial dysfunction in preeclampsia via drug repurposing.

  2025cites this paper
• Targeting oxidative stress in preeclampsia

  2024cites this paper
• Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine

  2024cites this paper
• Untargeted metabolomics to discriminate liver and lung hydatid cysts: Importance of metabolites involved in the immune response.

  2024cites this paper
• Metabolomic Profile Alterations Associated with the SLC16A11 Risk Haplotype Following a Lifestyle Intervention in People With Prediabetes

  2024cites this paper
• Optimized Nutrition in Mitochondrial Disease Correlates to Improved Muscle Fatigue, Strength, and Quality of Life

  2023cites this paper
• Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs

  2022cites this paper
• Mitochondrial DNA replication and repair defects: Clinical phenotypes and therapeutic interventions.

  2022cites this paper
• Therapy Prospects for Mitochondrial DNA Maintenance Disorders

  2021cites this paper
• Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders

  2021cites this paper
• Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease—Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors

  2021influential citation
• Leigh Syndrome: A Tale of Two Genomes

  2021cites this paper
• Mitochondrial Genome (mtDNA) and Human Diseases

  2021cites this paper
• Nutrition, Bioenergetics, and Metabolic Syndrome

  2020cites this paper
• Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines

  2020cites this paper
• Integrating genetic, epigenetic and environmental information to improve health and well-being

  2020cites this paper
• Nutrients, Mitochondrial Function, and Perinatal Health

  2020cites this paper
• Flavin dependency undermines proteome stability, lipid metabolism and cellular proliferation during vitamin B2 deficiency

  2020cites this paper
• The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery

  2020cites this paper
• Experimental Therapies

  2019cites this paper
• Nutritional Regulation of Mitochondrial Function

  2019cites this paper
• N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.

  2018cites this paper
• Mitochondrial Disease: Advances in Clinical Diagnosis, Management, Therapeutic Development, and Preventative Strategies

  2018cites this paper
• Towards a therapy for mitochondrial disease: an update

  2018cites this paper
• A New Approach to Treating Neurodegenerative Otologic Disorders

  2018influential citation